Search research articles
Contact Us
Filters
Showing results (191-200 of 236) with videos related to
Page
of 24
Sort By:
Clinical Neuropharmacology
|
August 1, 1996
An electromyographic marker for neuroleptic-induced akathisia: preliminary measures of sensitivity and specificity
S L Cunningham, J W Winkelman, C M Dorsey, et al.
The American Journal of Medicine
|
May 12, 1998
What proportion of common diagnostic tests appear redundant?
D W Bates, D L Boyle, E Rittenberg, et al.
Mayo Clinic Proceedings
|
January 7, 2018
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome
Michael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 15, 2018
Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)<sup>§</sup>
Juliane Winkelmann, Richard P Allen, Birgit Högl, et al.
Sleep Medicine Reviews
|
February 10, 2026
Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review
Andrew Krystal, Ruth Benca, William V McCall, et al.
American Journal of Clinical Pathology
|
March 8, 2000
Appropriateness of prostate-specific antigen testing
H T Poteat, P Chen, K R Loughlin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2016
Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial
Yves Dauvilliers, Heike Benes, Markku Partinen, et al.
Mayo Clinic Proceedings
|
July 7, 2018
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome
Michael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 18, 2019
Reply to: Safety of dopamine agonists for treating restless legs syndrome
Aaro V Salminen, Richard P Allen, Birgit Högl, et al.
Cancer Research
|
October 23, 1997
Photodynamic therapy using a protoporphyrinogen oxidase inhibitor
V H Fingar, T J Wieman, K S McMahon, et al.
Page
of 24
Search research articles
Search
Showing results (191-200 of 236) with videos related to
Sort By:
Page
of 24
Clinical Neuropharmacology
|
August 1, 1996
An electromyographic marker for neuroleptic-induced akathisia: preliminary measures of sensitivity and specificity
S L Cunningham, J W Winkelman, C M Dorsey, et al.
The American Journal of Medicine
|
May 12, 1998
What proportion of common diagnostic tests appear redundant?
D W Bates, D L Boyle, E Rittenberg, et al.
Mayo Clinic Proceedings
|
January 7, 2018
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome
Michael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 15, 2018
Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)<sup>§</sup>
Juliane Winkelmann, Richard P Allen, Birgit Högl, et al.
Sleep Medicine Reviews
|
February 10, 2026
Pharmacologic treatment data from chronic insomnia studies and the application to individuals with acute insomnia, a narrative review
Andrew Krystal, Ruth Benca, William V McCall, et al.
American Journal of Clinical Pathology
|
March 8, 2000
Appropriateness of prostate-specific antigen testing
H T Poteat, P Chen, K R Loughlin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 7, 2016
Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial
Yves Dauvilliers, Heike Benes, Markku Partinen, et al.
Mayo Clinic Proceedings
|
July 7, 2018
In Reply-Additional Safety Considerations Before Prescribing Opioids to Manage Restless Legs Syndrome
Michael H Silber, Philip M Becker, Mark J Buchfuhrer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 18, 2019
Reply to: Safety of dopamine agonists for treating restless legs syndrome
Aaro V Salminen, Richard P Allen, Birgit Högl, et al.
Cancer Research
|
October 23, 1997
Photodynamic therapy using a protoporphyrinogen oxidase inhibitor
V H Fingar, T J Wieman, K S McMahon, et al.
Page
of 24